Genentech: The Beginnings of Biotech (Synthesis)

Valutazione media 4,06
( su 134 valutazioni fornite da Goodreads )
 
9780226045511: Genentech: The Beginnings of Biotech (Synthesis)

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech’s improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech’s science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech’s founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Integrating the scientific, the corporate, the contextual, and the personal, Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.  

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

About the Author:

Sally Smith Hughes is a historian of science at the Bancroft Library at the University of California, Berkeley. She is the author of The Virus: A History of the Concept and the creator of an extensive collection of in-depth oral histories on bioscience, biomedicine, and biotechnology.

Review:

“Hughes has crafted an engaging historical account of Genentech from its beginnings as a small laboratory at the University of California, San Francisco to the 2009 merger with Roche for 47 billion dollars. . . . [Her] account will appeal to a broad audience and is a must read for scholars interested in the history of biotechnology. Highly recommended.” (J. A. Hewlett Choice)

“[A]n important addition to the history of biotech.” (Phillip A. Sharp, Massachusetts Institute of Technology Nature Medicine)

“Over the past 20 years Sally Smith Hughes has done a great service to science studies by conducting in-depth oral-history interviews with prominent scientists, venture capitalists, corporate leaders, and attorneys in the history and business of early biotechnology. She drew on her unprecedented access to corporate records and a large number of actors and their oral histories to write Genentech, the first comprehensive account of the creation and early development of the Genentech Corporation.”
(Doogab Yi Chemical Heritage Magazine)

“The author skillfully reveals the practical, day-to-day, hands-on roles played by venture capitalists focused on fiscal gain and scientists focused on scientific breakthroughs. . . . [A] fascinating read.” (Valerie McGurk Nursing Standard)

“[A]n eminently readable (and, for classes, eminently assignable) story . . . . Smith Hughes is one of the foremost oral historians of science today, and Genentech is filled with illuminating interview snippets woven artfully into a narrative that both engages and (somewhat surreptitiously) analyzes. . . . [F]or a case study that lays out in lively detail the ambiguities and exuberances of high-tech entrepreneurship, Smith Hughes’s Genentech surely ranks among the very best.” (Cyrus C. M. Mody, Rice University Bulletin of the History of Medicine)

“[A] fascinating book, vividly recount[ing] the blood, sweat, and tears of the early days of ‘genetic engineers’ working at the bench, designing new biomolecules, and capitalizing their promises on Wall Street.” (Social History of Medicine)

Genentech: The Beginnings of Biotech paints a wonderfully detailed picture of an important beginning in the history of biotechnology.” (Nathan Crowe, Arizona State University Journal of the History of Biology)

“Hughes’s Genentech makes an invaluable international contribution to understanding how a period just short of a decade redefined ‘business as usual’ for biologists.” (Lisa Onaga, Nanyang Technological University Technology and Culture)

"Sally Smith Hughes skillfully describes the improbable creation, difficult adolescence, immense prosperity, and eventual foundering of Genentech, the first biotech behemoth. It’s a great tale, with a cast of fabulous characters and surprising episodes, ranging from Palo Alto to Wall Street. This is an outstanding book that should appeal to Nobel laureates as well as hedge-fund barons and ordinary citizens.”

(Daniel S. Greenberg, author of Science for Sale and Tech Transfer)

“Drawing extensively on oral histories, Hughes reveals the day-to-day hands-on roles of both the venture capitalists and the scientists, their eyes fixed at once on scientific triumphs and corporate riches, who brought Genentech to life. Hughes vividly recounts the tough-minded deals, buccaneering strategies, laboratory struggles, and relentless patent arrangements that not only made for Genentech’s success but that pioneered the new biotechnology industry’s operational model.” (Daniel Kevles, Yale University)

“Sally Smith Hughes’s book on the formative years of Genentech helps fill a gaping hole in the history of biotechnology, as it grew out of the recombinant DNA technology in the 1970s and 1980s. This book covers the quake from its epicenter. It draws on two decades of research, thousands of conversations, hundreds of documents, and dozens of oral history interviews. This zippy read will be welcomed by those who care about the San Francisco Bay area, biotechnology, the history of molecular biology, and high-tech economic development. Genentech has long had its legends, statues, buildings, and view of Candlestick Park; now it has a book about its beginnings.” (Robert Cook-Deegan, Duke University)

“My first job out of my postdoc was at Genentech in early 1981. At the time, I had no idea that all those guys in suits were doing something that had never been done before. But I did know the science was amazing—and Bob Swanson was the clear leader in creating an environment that supported that science. Sally Smith Hughes has brought to life the details of what the key players were up to—they weren’t playing it safe, and they created a catalytic environment that generated a whole new industry.” (Cynthia Robbins-Roth, author of From Alchemy to IPO)

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

I migliori risultati di ricerca su AbeBooks

1.

Sally Smith Hughes
Editore: The University of Chicago Press, United States (2013)
ISBN 10: 022604551X ISBN 13: 9780226045511
Nuovi Paperback Quantità: 1
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro The University of Chicago Press, United States, 2013. Paperback. Condizione libro: New. Reprint. Language: English . Brand New Book. In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech s improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech s science and business, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech s founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it. Codice libro della libreria AAS9780226045511

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 11,42
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

2.

Sally Smith Hughes
Editore: University of Chicago Press (2013)
ISBN 10: 022604551X ISBN 13: 9780226045511
Nuovi Quantità: > 20
Da
Pbshop
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro University of Chicago Press, 2013. PAP. Condizione libro: New. New Book.Shipped from US within 10 to 14 business days. Established seller since 2000. Codice libro della libreria IB-9780226045511

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 8,44
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,42
In U.S.A.
Destinazione, tempi e costi

3.

Hughes, Sally Smith
ISBN 10: 022604551X ISBN 13: 9780226045511
Nuovi Quantità: 9
Da
Paperbackshop-US
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro 2013. PAP. Condizione libro: New. New Book. Shipped from US within 10 to 14 business days. Established seller since 2000. Codice libro della libreria TX-9780226045511

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 8,44
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,42
In U.S.A.
Destinazione, tempi e costi

4.

Sally Smith Hughes
Editore: The University of Chicago Press, United States (2013)
ISBN 10: 022604551X ISBN 13: 9780226045511
Nuovi Paperback Quantità: 1
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro The University of Chicago Press, United States, 2013. Paperback. Condizione libro: New. Reprint. Language: English . Brand New Book. In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech s improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech s science and business, and in doing so sheds new light on how personality affects the growth of science.By placing Genentech s founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it. Codice libro della libreria AAS9780226045511

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 11,95
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

5.

Sally Smith Hughes
Editore: The University of Chicago Press, United States (2013)
ISBN 10: 022604551X ISBN 13: 9780226045511
Nuovi Paperback Quantità: 1
Da
Book Depository hard to find
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro The University of Chicago Press, United States, 2013. Paperback. Condizione libro: New. Reprint. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech s improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech s science and business, and in doing so sheds new light on how personality affects the growth of science.By placing Genentech s founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it. Codice libro della libreria BTE9780226045511

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 12,03
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

6.

Hughes, Sally Smith
ISBN 10: 022604551X ISBN 13: 9780226045511
Nuovi Paperback Quantità: > 20
Da
BargainBookStores
(Grand Rapids, MI, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Paperback. Condizione libro: New. Codice libro della libreria 6400279

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 9,31
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,42
In U.S.A.
Destinazione, tempi e costi

7.

Hughes, Sally Smith
Editore: University Of Chicago Press
ISBN 10: 022604551X ISBN 13: 9780226045511
Nuovi PAPERBACK Quantità: 3
Da
Lakeside Books
(Benton Harbor, MI, U.S.A.)
Valutazione libreria
[?]

Descrizione libro University Of Chicago Press. PAPERBACK. Condizione libro: New. 022604551X BRAND NEW, GIFT QUALITY! NOT OVERSTOCKS OR MARKED UP REMAINDERS! DIRECT FROM THE PUBLISHER!|0.7. Codice libro della libreria OTF-Y-9780226045511

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 10,06
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,42
In U.S.A.
Destinazione, tempi e costi

8.

Hughes, Sally Smith
Editore: University Of Chicago Press
ISBN 10: 022604551X ISBN 13: 9780226045511
Nuovi PAPERBACK Quantità: 1
Da
Qwestbooks COM LLC
(Bensalem, PA, U.S.A.)
Valutazione libreria
[?]

Descrizione libro University Of Chicago Press. PAPERBACK. Condizione libro: New. 022604551X. Codice libro della libreria Z022604551XZN

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 13,50
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

9.

Hughes, Sally Smith
Editore: University Of Chicago Press (2013)
ISBN 10: 022604551X ISBN 13: 9780226045511
Nuovi Paperback Quantità: 6
Da
Murray Media
(North Miami Beach, FL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro University Of Chicago Press, 2013. Paperback. Condizione libro: New. Codice libro della libreria 022604551X

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 11,21
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 2,56
In U.S.A.
Destinazione, tempi e costi

10.

Sally Smith Hughes
ISBN 10: 022604551X ISBN 13: 9780226045511
Nuovi Paperback Quantità: 1
Da
Grand Eagle Retail
(Wilmington, DE, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Paperback. Condizione libro: New. Paperback. In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public sto.Shipping may be from multiple locations in the US or from the UK, depending on stock availability. 213 pages. 0.318. Codice libro della libreria 9780226045511

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 15,12
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

Vedi altre copie di questo libro

Vedi tutti i risultati per questo libro